Hookipa Pharma Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Hookipa Pharma Stock Summary

Hookipa Pharma competes with Mereo BioPharma, Terns Pharmaceuticals, PDS Biotechnology, Inozyme Pharma, and Day One. HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company was incorporated in 2011 and is headquartered in New York, New York. Hookipa Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 131 people.

Hookipa Pharma Key Financial Ratios

Hookipa Pharma Key Balance Sheet Accounts

Hookipa Pharma Key Income Statement Accounts

Hookipa Pharma Key Cash Accounts

Hookipa Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Hookipa Pharma's current stock value. Our valuation model uses many indicators to compare Hookipa Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Hookipa Pharma competition to find correlations between indicators driving Hookipa Pharma's intrinsic value. More Info.Hookipa Pharma is rated below average in return on equity category among its peers. It is rated # 3 in return on asset category among its peers . At this time, Hookipa Pharma's Return On Equity is quite stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Hookipa Pharma by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Hookipa Pharma Systematic Risk

Today, most investors in Hookipa Pharma Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Hookipa Pharma's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Hookipa Pharma growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Hookipa Pharma help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Hookipa Pharma. We use our internally-developed statistical techniques to arrive at the intrinsic value of Hookipa Pharma based on widely used predictive technical indicators. In general, we focus on analyzing Hookipa Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Hookipa Pharma's daily price indicators and compare them against related drivers.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hookipa Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. For more information on how to buy Hookipa Stock please use our How to buy in Hookipa Stock guide.You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Hookipa Pharma. If investors know Hookipa will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Hookipa Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Hookipa Pharma is measured differently than its book value, which is the value of Hookipa that is recorded on the company's balance sheet. Investors also form their own opinion of Hookipa Pharma's value that differs from its market value or its book value, called intrinsic value, which is Hookipa Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Hookipa Pharma's market value can be influenced by many factors that don't directly affect Hookipa Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Hookipa Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Hookipa Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hookipa Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.